Direction, evidence grade, and study type are AI-generated labels (gpt-5-mini), not human-verified. Syntheses are LLM-written. "Tensions" are machine-detected candidates, not confirmed contradictions. A research-acceleration tool, not peer review.
How this is built →
1Distinct papers
2Unique collaborators
1/1OpenAlex citation coverage
Publication span: 2026. Corpus fetch span: 2026.
Identity provenance
Provider IDs
- Openalex:
A5101124643
ORCID evidence
No valid ORCID is stored.
Observed aliases (2)
- Shuping Lin (openalex, provider refresh)
- Shuping Lin (openalex, source metadata)
Topics and outcomes in this view
Assessment themes
- Governance: 1 paper
- Innovation: 1 paper
- Productivity: 1 paper
Claim outcomes
- Market Structure: 1 paper
- Organizational Efficiency: 1 paper
Papers in the OpenAlex view
Latest stored OpenAlex author observations only. Citation counts below are from the same provider and are not combined with other services.
Scroll the table horizontally to see every column.
| Paper | Author evidence | Date | Provider citations |
|---|---|---|---|
| China’s sci‑tech finance pilot cut listed firms’ downside tail risk by loosening funding bottlenecks and improving disclosure; effects were largest for private, digitally advanced firms in regions with stronger IP protection and better governance.openalex | Shuping Lin provider id |
2026-08-16 | 0 |
Citation observation summary
OpenAlex supplied counts for 1 of 1 papers in this view; 0 are missing. The observed paper counts sum to 0 cumulative citations. This is a coverage summary, not an author score or h-index.